Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Delay aversion and Executive Functioning in adults with Attention-Deficit/Hyperactivity Disorder: Before and after stimulant treatment

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Altered Expression Pattern of Clock Genes in a Rat Model of Depression

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background: ADHD is a heterogeneous disorder, associated with deficits in motivation (e.g., delay aversion) and cognition. Methylphenidate is recommended as a first line treatment for ADHD symptoms, but little is known about its non-acute effects on motivational and cognitive deficits, particularly in adults with ADHD.

Methods: We utilized a prospective, non-randomized, non-blinded, six-week follow-up design with 42 initially stimulant medication-naïve adult patients with moderate to severe ADHD, and 42 age- and parental education-matched healthy controls. DA and EF were assessed with two questionnaires and five performance-based tests.

Results: At baseline, patients and controls differed significantly on performance-based measures (moderate to large effect sizes), and self-report of DA and EF (very large effect sizes). Treatment with methylphenidate medication (mean dose 65.54 mg/day, SD = 10.39) was not associated with improvements in performance-based measures of DA and EF compared to controls, although improvements in self-report EF and DA were found. Self-reported DA was most consistently associated with ADHD symptomatology at baseline and after medication.

Conclusion: Methylphenidate treatment does not have an effect on performance-based measures of DA and EFs, but may have significant effects on self-reported DA and EFs. The latter finding should be interpreted cautiously, given the subjective nature of these measures and design limitations. Self-reported DA is most consistently associated with ADHD symptomatology.

Original languageEnglish
JournalInternational Journal of Neuropsychopharmacology
Volume21
Issue number11
Pages (from-to)997-1006
Number of pages10
ISSN1461-1457
DOIs
Publication statusPublished - 1 Nov 2018

ID: 55046491